Darya-Varia Laboratoria Tbk logo

Darya-Varia Laboratoria Tbk (DVLA)

Market Closed
15 Dec, 08:49
IDX IDX
Rp
1,650. 00
+5
+0.3%
Rp
1.83T Market Cap
- P/E Ratio
172% Div Yield
46,300 Volume
- Eps
Rp 1,645
Previous Close
Day Range
1,645 1,675
Year Range
1,325 1,775
Want to track DVLA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

DVLA closed today higher at Rp1,650, an increase of 0.3% from yesterday's close, completing a monthly decrease of -1.2% or Rp20. Over the past 12 months, DVLA stock gained 3.12%.
DVLA pays dividends to its shareholders, with the most recent payment made on Nov 17, 2025. The next estimated payment will be in 4 weeks ago on Nov 17, 2025 for a total of Rp41.
The last earnings report, released on Oct 28, 2016, exceeded the consensus estimates by 48.38%. On average, the company has surpassed earnings expectations by 41.04%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 1 different exchanges and in various currencies, with the primary listing on IDX (IDR).

DVLA Chart

Similar

Daya Intiguna Yasa Tbk. PT
Rp 1,015
0%
Industri Jamu dan Farmasi Sido Muncul Tbk.
Rp 550
+3.77%
Astra Otoparts Tbk.
Rp 2,730
+1.49%
Selamat Sempurna Tbk
Rp 1,735
+0.58%
Tempo Scan Pacific Tbk.
Rp 2,850
+2.89%

Darya-Varia Laboratoria Tbk (DVLA) FAQ

What is the stock price today?

The current price is Rp1,650.00.

On which exchange is it traded?

Darya-Varia Laboratoria Tbk is listed on IDX.

What is its stock symbol?

The ticker symbol is DVLA.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 172%.

What is its market cap?

As of today, the market cap is 1.83T.

Has Darya-Varia Laboratoria Tbk ever had a stock split?

No, there has never been a stock split.

Darya-Varia Laboratoria Tbk Profile

Specialty Retail Industry
Consumer Discretionary Sector
- CEO
IDX Exchange
ID1000117203 ISIN
Indonesia Country
1,266 Employees
29 Oct 2025 Last Dividend
12 Nov 2010 Last Split
- IPO Date

Overview

PT Darya-Varia Laboratoria Tbk is a prominent entity in the Indonesian pharmaceutical and cosmetics industry, with a foundation laid in 1976. Based in Jakarta, Indonesia, it plays a vital role in manufacturing and trading a substantial range of pharmaceutical products and cosmetics. Operating across four main segments: Prescription Drugs, Consumer Health Products, Export, and Toll Manufacturing Services, and Services, the company has carved a niche for itself in the healthcare sector. As a subsidiary of Blue Sphere Singapore Pte. Ltd., it has expanded its reach beyond Indonesian borders, exporting products to countries including Malaysia, Myanmar, the Philippines, Singapore, Vietnam, and Mongolia.

Products and Services

Prescription Drugs: Offering a broad spectrum of prescription products targeting various health concerns such as cardiology, gastro-hepatology, antibiotics, women's healthcare, and more. This segment includes specialized areas like dermamedic, somatic, cough, and cold remedies, along with antibiotics and a comprehensive range of vitamins and food supplements. Additionally, it caters to niche medical areas including plastic surgery, general surgery, burn and trauma wound care, aesthetic medicine, ear healthcare, and central nerve systems treatments.

Consumer Health Products: This category features a diverse lineup, including:

  • Skin Nutrition: Marketed under the Natur-E brand, focusing on skin health and nutrition.
  • Respiratory Products: Includes brands like Decolgen, ALLERIN EXPECTORANT, and Decolsin, among others, targeting nasal congestion, cough, and breathing issues triggered by allergies.
  • Multivitamins and Vitamin C: Offered under the Enervon-C, Enervon Active, Enervon Gold, Supertin, and Vicee brands, designed to bolster general health.
  • Supplements for Kids: The Imunped brand is specifically formulated with Zinc and Vitamin C to support children's immune systems.
  • Pain Management: Biogesic is designed to alleviate various types of pain efficiently.
  • Anti-Diarrhea and Digestive Health: Diatabs and New Enzyplex are developed for managing diarrhea and preventing indigestion, respectively.

Toll Manufacturing Services: PT Darya-Varia Laboratoria Tbk offers comprehensive toll manufacturing services, specializing in the production of soft gelatin capsules, sterile injections, and low volume solid products. These services extend their manufacturing expertise to other companies needing high-quality pharmaceutical manufacturing capabilities.

Export: Besides catering to the domestic market, the company has an established presence in the international arena, exporting its wide range of pharmaceutical products and services to several countries in the Southeast Asian region and beyond. This global outreach helps in promoting Indonesian pharmaceuticals on a wider scale.

Contact Information

Address: Tower C
Phone: 62 21 227 68000